Search results (229)
« Back to News
Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material
8 Oct, 2026
New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.
Meeting the neuroscientists at Meeting Minds
29 Sep, 2026
Ben Seymour and Masud Husain joined the line up of speakers at this year's Meeting Minds event for Oxford alumni on 19 September
Oxford researchers uncover how Parkinson's disease protein damages brain cells
5 Aug, 2026
A new study reveals a key mechanism by which the protein alpha-synuclein, the hallmark of Parkinson's disease, damages neurons (brain cells) by blocking a vital cellular gateway. The results of the study, published in Nature Communications, help to explain how the disease begins and highlights a potential new target for treatment.
New Lancet review calls for urgent action to tackle the growing global threat of encephalitis
19 Jun, 2026
The review highlights encephalitis as an urgent global health challenge and calling for faster diagnosis, improved treatments, and strengthened prevention strategies to reduce death and disability worldwide.
Dr Ruxandra Dafinca awarded an Alzheimer’s Society Dementia Research Leader Fellowship
4 Jun, 2026
Ruxandra Dafinca is one of 17 early career researchers awarded a fellowship in the 2025/2026 call for her project focused on frontotemporal dementia.
Two researchers from NDCN join global network to unravel the complexity of Parkinson’s disease
13 May, 2026
Two scientists from NDCN, Professor Andrew Sharott (Team leader) and Professor Laura Parkkinen (Co-Investigator) have been selected for multi-year grants to join the Collaborative Research Network (CRN) an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease.
Study shows that non-invasive ultrasound shows promise for treating Parkinson’s disease
1 May, 2026
Oxford researchers have shown for the first time that ultrasound could have similar effects on brain activity in Parkinson’s sufferers as implanted deep brain stimulation (DBS) electrodes. This opens the door to new treatment approaches that could avoid surgery.
Collaboration with the Nepal Public Health Foundation (NPHF) explores maternal health and epilepsy
26 Mar, 2026
A new study, co-led by Professor Arjune Sen and supported by Nuffield Department of Clinical Neurosciences, aims to improve understanding of the risk factors, care pathways and broader health and social impacts of epilepsy in Nepal.
Professor Chrystalina Antoniades awarded Suffrage Science Award in Life Sciences 2026
17 Mar, 2026
The awards took place in Oxford University's Science Area to celebrate the achievements of inspiring women in the life sciences
New funding boosts Oxford research into inflammatory neuropathies
26 Feb, 2026
To mark Rare Disease Day on 28 February, we’re highlighting the research of Professor Simon Rinaldi and Dr Nicolas Dubuisson, and celebrating a major new $600,000 grant to progress their fight against inflammatory neuropathies.
NDCN professors amongst first Group Leaders announced for new dedicated Parkinson's Research Centre
19 Feb, 2026
Professors Laura Parkkinen and Peter Magill have been appointed to UK DRI Group Leader roles.
Oxford-Harrington Rare Disease Centre Announces 2025 Scholars
16 Dec, 2025
Esther Becker is one of ten recipients of the 2025 Rare Disease Scholar Award, which advances promising discoveries from academic labs into clinical practice.
Oxford researchers to redefine new human-based research models of pain
11 Nov, 2025
An interdisciplinary team led by Professor Zameel Cader is part of a major new initiative which aims to redefine human-based research models for greater understanding of disease and the acceleration of new medicines.
New Oxford-led project aims to revolutionise chronic pain treatment
17 Oct, 2025
The University of Oxford is to lead a new six-year, £11 million project backed by the Engineering and Physical Sciences Research Council (EPSRC) which aims develop a new generation of personalised treatments capable of reducing or abolishing chronic pain.
Oxford Cancer announces 2025 CRIS Cancer Clinical Career Fellows
13 Oct, 2025
Oxford Cancer, together with the CRIS Cancer Foundation, is delighted to announce the appointment of the 2025 CRIS Cancer Postdoctoral Clinical Fellows: Dr Rebecca Ling and Dr Casmir Turnquist
Masud Husain wins 2025 Royal Society Trivedi Book Prize
9 Oct, 2025
The prize was awarded for 'Our Brains, Our Selves: What a Neurologist's Patients Taught Him About the Brain'
NeuroMetrology Lab advance Parkinson’s Disease research with the Opal® Wearable Sensor System
6 Oct, 2025
A partnership with Clario focuses on advancing the use of wearable sensors to enable more precise measurement of motor symptoms and disease progression in Parkinson's.
'A community within a community' - reflections of CNS co-chairs
2 Sep, 2025
Postdoctoral researchers Danielle Hewitt and Maddalena Comini reflect on their time as Clinical Neurosciences Society (CNS) Co-Chairs.
Exceptional Oxford researchers awarded first Royal Society Faraday Discovery Fellowships
28 Aug, 2025
Three pioneering Oxford researchers, including Professor Timothy Behrens from NDCN, are among the first recipients of the Royal Society Faraday Discovery Fellowships, prestigious long-term awards to support exceptional mid-career research leaders in the UK. Only seven academics were selected in total from more than 600 initial applications.